What is a stock summary page? Click here for an overview.
Business Description
Hubei Guangji Pharmaceutical Co Ltd
NAICS : 325411
SIC : 2834
ISIN : CNE0000010R5
Share Class Description:
SZSE:000952: Class ACompare
Compare
Traded in other countries / regions
000952.China IPO Date
1999-11-12Description
Hubei Guangji Pharmaceutical Co Ltd is engaged in the manufacture and sale of raw pharmaceutical products, medicinal feed additives, fine chemicals and preparations in China. Geographically the business activities are carried out through China, however, more than 60 percent of its main products are exported to over 30 countries and regions all over the world.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.39 | |||||
| Equity-to-Asset | 0.39 | |||||
| Debt-to-Equity | 0.91 | |||||
| Debt-to-EBITDA | -6.17 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.73 | |||||
| Beneish M-Score | -2.91 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.3 | |||||
| 3-Year EBITDA Growth Rate | -49.7 | |||||
| 3-Year Book Growth Rate | -0.9 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.36 | |||||
| 9-Day RSI | 38.29 | |||||
| 14-Day RSI | 39.96 | |||||
| 3-1 Month Momentum % | 5.29 | |||||
| 6-1 Month Momentum % | 3.96 | |||||
| 12-1 Month Momentum % | -2.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.98 | |||||
| Quick Ratio | 0.67 | |||||
| Cash Ratio | 0.36 | |||||
| Days Inventory | 239.5 | |||||
| Days Sales Outstanding | 118.29 | |||||
| Days Payable | 96.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.7 | |||||
| Shareholder Yield % | -12.25 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 23.31 | |||||
| Operating Margin % | -21.96 | |||||
| Net Margin % | -34.22 | |||||
| FCF Margin % | -28.39 | |||||
| ROE % | -17.63 | |||||
| ROA % | -7.5 | |||||
| ROIC % | -5.89 | |||||
| 3-Year ROIIC % | -15.84 | |||||
| ROC (Joel Greenblatt) % | -9.58 | |||||
| ROCE % | -8.42 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 42.67 | |||||
| PS Ratio | 2.69 | |||||
| PB Ratio | 1.49 | |||||
| Price-to-Tangible-Book | 1.81 | |||||
| EV-to-EBIT | -14.11 | |||||
| EV-to-EBITDA | -14.11 | |||||
| EV-to-Revenue | 3.69 | |||||
| EV-to-FCF | -12.67 | |||||
| Price-to-GF-Value | 0.8 | |||||
| Price-to-Median-PS-Value | 0.74 | |||||
| Earnings Yield (Greenblatt) % | -7.09 | |||||
| FCF Yield % | -10.74 | |||||
| Forward Rate of Return (Yacktman) % | -44.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hubei Guangji Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 677.519 | ||
| EPS (TTM) (Â¥) | -0.657 | ||
| Beta | 0.91 | ||
| 3-Year Sharpe Ratio | -0.52 | ||
| 3-Year Sortino Ratio | -0.64 | ||
| Volatility % | 30.3 | ||
| 14-Day RSI | 39.96 | ||
| 14-Day ATR (Â¥) | 0.272315 | ||
| 20-Day SMA (Â¥) | 5.598 | ||
| 12-1 Month Momentum % | -2.04 | ||
| 52-Week Range (Â¥) | 4.63 - 7.85 | ||
| Shares Outstanding (Mil) | 349.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hubei Guangji Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hubei Guangji Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hubei Guangji Pharmaceutical Co Ltd Frequently Asked Questions
What is Hubei Guangji Pharmaceutical Co Ltd(SZSE:000952)'s stock price today?
The current price of SZSE:000952 is ¥5.12. The 52 week high of SZSE:000952 is ¥7.85 and 52 week low is ¥4.63.
When is next earnings date of Hubei Guangji Pharmaceutical Co Ltd(SZSE:000952)?
The next earnings date of Hubei Guangji Pharmaceutical Co Ltd(SZSE:000952) is .
Does Hubei Guangji Pharmaceutical Co Ltd(SZSE:000952) pay dividends? If so, how much?
Hubei Guangji Pharmaceutical Co Ltd(SZSE:000952) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers